Prevalence of very high cardiovascular disease risk in patients with type 2 diabetes mellitus: A population‐based cross‐sectional screening study
Authors' conclusion
This study represented the largest observational study of CVD risk assessment in patients with T2DM in China. The CVD risk situation of patients with diabetes in China is critical, and comprehensive control and management of CVD risk factors, such as hypertension, BMI and dyslipidaemia, in patients with DM need to be strengthened in patients with T2DM in China.
Study context
- Population
- Patients with T2D, 1669 hospitals in 30 provinces of China (excluding Tibet, Taiwan, Hong Kong and Macao), 2020–2022; CVD risk categorized per 2019 ESC/EASD guidelines
- Participants
- 1,870,720 patients1,669 hospitals
- Outcome
- Prevalence of very high CVD risk (2019 ESC/EASD guidelines)
Methodological detailspopulation-based, screening, multicentre, Data collected by professionally trained physicians, 1 January 2020 to 30 December 2022
- Population-based
- Screening
- Multicentre
- Data collected by professionally trained physicians, 1 January 2020 to 30 December 2022
Main finding
As reported in the abstract
Very high CVD risk in T2D
- Patients with T2D at very high risk for CVD
- 67.50%
- Very high-risk T2D, Northeast China
- 75.82%
- Very high-risk T2D, Central China
- 73.65%
- Very high-risk T2D, Southwest China
- 72.66%
- Very high-risk T2D, Southern China (lowest)
- 60.15%
Observational data: associations, not effects.
Further findings
Factors associated with very high CVD risk (multivariate binary logistic regression)
- Age: OR (95% CI) 1.04 (1.04-1.04), p < .0001
- Body mass index (BMI): OR (95% CI) 1.07 (1.07-1.07), p < .0001
- Duration of diabetes mellitus (DM): OR (95% CI) 1.05 (1.05-1.05), p < .0001
- Hypertension: OR (95% CI) 3.75 (3.72-3.78), p < .0001
- Dyslipidaemia: OR (95% CI) 5.22 (5.18-5.27), p < .0001
- Smoking: OR (95% CI) 2.92 (2.89-2.95), p < .0001
Original publication
Prevalence of very high cardiovascular disease risk in patients with type 2 diabetes mellitus: A population‐based cross‐sectional screening study. Diabetes Obes Metab. Published 17 July 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →